Hybrid Plasmonic Photoreactors as Visible Light-Mediated Bactericides.
Photocatalytic compounds and complexes, such as tris(bipyridine)ruthenium(II), [Ru(bpy)3]2+, have recently received attention as light-mediated bactericides that can help to address the need for new antibacterial strategies. We demonstrate in this work that the bactericidal efficacy of [Ru(bpy)3]2+ and the control of its antibacterial function can be significantly enhanced through combination with a plasmonic nanoantenna. We report strong, visible light-controlled bacterial inactivation with a nanocomposite design that incorporates [Ru(bpy)3]2+ as photocatalyst and a Ag nanoparticle (NP) core as light-concentrating nanoantenna into a plasmonic hybrid photoreactor. The hybrid photoreactor platform is facilitated by a self-assembled lipid membrane that encapsulates the Ag NP and binds the photocatalyst. The lipid membrane renders the nanocomposite biocompatible in the absence of resonant illumination. Upon illumination, the plasmon-enhanced photoexcitation of the metal-to-ligand-charge-transfer band of [Ru(bpy)3]2+ prepares the reactive excited state of the complex that oxidizes the nanocomposite membrane and increases its permeability. The photooxidation induces the release of [Ru(bpy)3]2+, Ag+, and peroxidized lipids into the ambient medium, where they interact synergistically to inactivate bacteria. We measured seven orders of magnitude decrease in Gram-positive Arthrobacter sp. and four orders of magnitude decrease in Gram-negative Escherichia coli (E. coli) colony forming units (CFUs) with the photoreactor bactericides after 1-hour of visible light illumination. In both cases the photoreactor exceeds the bactericidal standard of a log reduction value (LRV) of 3, and surpasses the antibacterial effect of free Ag NPs or [Ru(bpy)3]2+ by more than four orders of magnitude. We also implement the inactivation of a bacterial thin film in a proof-of-concept study.